Active Stocks

Wed Sep 27 2023 15:59:55

Tata Steel share price
128.15 -0.54%

HDFC Bank share price
1,527.2 -0.68%

Tata Motors share price
620.4 0.1%

NTPC share price
239.35 -0.35%

Infosys share price
1,467.55 0.51%

Business News/ Companies / News/ Germany’s Curevac expects EU nod for its Covid-19 vaccine in May

Back

Germany’s Curevac expects EU nod for its Covid-19 vaccine in May

1 min read 10 Apr 2021, 02:36 PM IST Join us

Reuters

Curevac says it is already very advanced in phase three clinical trials and is expecting the data for the final approval package

Curevac plans to produce up to 300 million vaccine doses this year. (AP) — Curevac plans to produce up to 300 million vaccine doses this year. **(AP)**

BERLIN : German biotech firm Curevac believes the European Union might give approval for its COVID-19 vaccine in May or June, a spokesman was quoted as saying in the Augsburger Allgemeine newspaper on Saturday.

"We are already very advanced in Phase Three clinical trials and are expecting the data for the final approval package," spokesman Thorsten Schueller told the paper.

Previously, approval was expected in June.

Curevac still plans to produce up to 300 million vaccine doses this year, the spokesman was quoted as saying.

"Exciting news! Mint is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest financial insights!" Click here!